Regulation of soluble epoxide hydrolase in renal-associated diseases: insights from potential mechanisms to clinical researches

In recent years, numerous experimental studies have underscored the pivotal role of soluble epoxide hydrolase (sEH) in renal diseases, demonstrating the reno-protective effects of sEH inhibitors. The nexus between sEH and renal-associated diseases has garnered escalating attention. This review endea...

Full description

Bibliographic Details
Published in:	Frontiers in Endocrinology
Main Authors:	Peng Gao, Yongtong Cao, Liang Ma
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Subjects:	soluble epoxide hydrolase sEH inhibitors renal diseases epoxyeicosatrienoic acids sEH polymorphisms
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1304547/full

Similar Items

The impact of the soluble epoxide hydrolase cascade on periodontal tissues
by: Henrique Ballassini Abdalla, et al.
Published: (2023-02-01)

Coumarin and Moracin Derivatives from Mulberry Leaves (<i>Morus alba</i> L.) with Soluble Epoxide Hydrolase Inhibitory Activity
by: Hong Xu Li, et al.
Published: (2020-08-01)

Evaluation of the Therapeutic Potential of Sulfonyl Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors
by: Biswajit Kundu, et al.
Published: (2024-06-01)

The role of CYP-sEH derived lipid mediators in regulating mitochondrial biology and cellular senescence: implications for the aging heart
by: Ala Yousef, et al.
Published: (2024-12-01)

CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory Mediators
by: Zeqi Shi, et al.
Published: (2022-06-01)

Essential Oils of <i>Laurus nobilis</i> L.: From Chemical Analysis to In Silico Investigation of Anti-Inflammatory Activity by Soluble Epoxide Hydrolase (sEH) Inhibition
by: Francesca Fantasma, et al.
Published: (2024-07-01)

Dissecting the Regulation of Arachidonic Acid Metabolites by Uncaria rhynchophylla (Miq). Miq. in Spontaneously Hypertensive Rats and the Predictive Target sEH in the Anti-Hypertensive Effect Based on Metabolomics and Molecular Docking
by: Lei Gao, et al.
Published: (2022-05-01)

Synthesis and structure–activity relationships for some novel diflapolin derivatives with benzimidazole subunit
by: Lisa Vieider, et al.
Published: (2022-12-01)

Association between the soluble epoxide hydrolase gene and preeclampsia
by: Ismail Sari, et al.
Published: (2017-10-01)

Inhibition of Soluble Epoxide Hydrolase for Renal Health
by: Jun-Yan Liu, et al.
Published: (2019-01-01)

EETs mediate cardioprotection of salvianolic acids through MAPK signaling pathway
by: Shoubao Wang, et al.
Published: (2013-02-01)

Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer’s Disease-Like Complications of Diabetes
by: Rohit Pardeshi, et al.
Published: (2019-04-01)

Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson’s Disease: A New Therapeutic Strategy
by: Mercè Pallàs, et al.
Published: (2020-05-01)

Inhibition of Soluble Epoxide Hydrolase Does Not Promote or Aggravate Pulmonary Hypertension in Rats
by: Matthieu Leuillier, et al.
Published: (2023-02-01)

Inhibition of soluble epoxide hydrolase confers neuroprotection and restores microglial homeostasis in a tauopathy mouse model
by: Shuo Wang, et al.
Published: (2025-04-01)

Dimethoxybenzohomoadamantane-based soluble epoxide hydrolase inhibitors: in vivo efficacy in a murine model of chemotherapy-induced neuropathic pain
by: Sandra Codony, et al.
Published: (2025-12-01)

The involvement of soluble epoxide hydrolase in the development of cardiovascular diseases through epoxyeicosatrienoic acids
by: Shan Jiang, et al.
Published: (2024-04-01)

Evaluation and clinical implications of interactions between compound Danshen dropping pill and warfarin associated with the epoxide hydrolase gene
by: Xixi Chen, et al.
Published: (2023-05-01)

Redox Regulation of Soluble Epoxide Hydrolase—Implications for Cardiovascular Health and Disease
by: Rebecca Charles, et al.
Published: (2022-06-01)

Association of the sEH gene promoter polymorphisms and haplotypes with preeclampsia
by: Sarı İsmail, et al.
Published: (2020-01-01)

Structure-guided discovery of potent and oral soluble epoxide hydrolase inhibitors for the treatment of neuropathic pain
by: Fangyu Du, et al.
Published: (2022-03-01)

Screening and Identification of Novel Soluble Epoxide Hydrolase Inhibitors from Corn Gluten Peptides
by: Jiamin Dang, et al.
Published: (2022-11-01)

Screening, Identification and Mechanism of Action of Cod-Derived Soluble Epoxide Hydrolase Inhibitory Peptides Based on Pharmacophore Model
by: LIU Pan, TU Maolin, LIU Hanxiong, CHENG Shuzhen, XU Xianbing, DU Ming
Published: (2023-03-01)

Inhibitory Activity of Quaternary Isoquinoline Alkaloids on Soluble Epoxide Hydrolase
by: Jang Hoon Kim, et al.
Published: (2022-09-01)

Inhibition of soluble epoxide hydrolase reverses bone loss in periodontitis by upregulating EMCN and inhibiting osteoclasts
by: Juanjuan Li, et al.
Published: (2024-11-01)

Sexually Dimorphic Regulation of EET Synthesis and Metabolism: Roles of Estrogen
by: An Huang, et al.
Published: (2018-10-01)

Synthesis and Properties of 1,3-Disubstituted Ureas Containing (Adamantan-1-yl)(phenyl)methyl Fragment Based on One-Pot Direct Adamantane Moiety Inclusion
by: Vladimir D’yachenko, et al.
Published: (2023-04-01)

Role of soluble epoxide hydrolase in pain and depression comorbidity
by: Yuchen Bu, et al.
Published: (2024-04-01)

Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease
by: Věra Čertíková Chábová, et al.
Published: (2018-03-01)

Inhibitory activity of lignanamides isolated from hemp seed hulls(Cannabis sativa L.) against soluble epoxide hydrolase
by: Jang Hoon Kim, et al.
Published: (2023-09-01)

Improving Solar Energy-Harvesting Wireless Sensor Network (SEH-WSN) with Hybrid Li-Fi/Wi-Fi, Integrating Markov Model, Sleep Scheduling, and Smart Switching Algorithms
by: Heba Allah Helmy, et al.
Published: (2025-09-01)

2-(Piperidin-4-yl)acetamides as Potent Inhibitors of Soluble Epoxide Hydrolase with Anti-Inflammatory Activity
by: Juan Martín-López, et al.
Published: (2021-12-01)

Soluble epoxide hydrolase modulates immune responses in activated astrocytes involving regulation of STAT3 activity
by: Chia-Chi Hung, et al.
Published: (2019-06-01)

Epoxide Hydrolase Inhibitors for the Treatment of Alzheimer’s Disease and Other Neurological Disorders: A Comprehensive Review
by: Manal Abdalla, et al.
Published: (2025-08-01)

Soluble Epoxide Hydrolase and Brain Cholesterol Metabolism
by: Michelle Flores Domingues, et al.
Published: (2020-01-01)

ZDHXB-101 (3′,5-Diallyl-2, 4′-dihydroxy-[1,1′-biphen-yl]-3,5′-dicarbaldehyde) protects against airway remodeling and hyperresponsiveness via inhibiting both the activation of the mitogen-activated protein kinase and the signal transducer and activator of transcription-3 signaling pathways
by: Jun-xia Jiang, et al.
Published: (2020-01-01)

Soluble Epoxide Hydrolase Inhibitory Activity of Selaginellin Derivatives from Selaginella tamariscina
by: Jang Hoon Kim, et al.
Published: (2015-12-01)

Hubungan Dzikir dengan Pengaturan Pernafasan dalam Pustaka Centhini
by: Muzairi Muzairi
Published: (2017-04-01)

Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients
by: Thomas Duflot, et al.
Published: (2019-03-01)

Soluble Epoxide Hydrolase Hepatic Deficiency Ameliorates Alcohol-Associated Liver Disease
by: Aline Mello, et al.
Published: (2021-01-01)